Quick Takeaways
- Charles McWherter has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Charles McWherter
- Location
- San Francisco, CA
- Signature
- /s/ Ryan A. Murr, as attorney-in-fact for Charles McWherter
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Charles McWherter and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: 89bio, Inc. ($0).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Charles McWherter
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ETNB | 89bio, Inc. | Director | $0 | 30 Oct 2025 | ||
| CBAY | CymaBay Therapeutics, Inc. | President of R&D | $0 | 22 Mar 2024 |
Insider Transactions Reported by Charles McWherter:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.